United States · 
Who invested in GeneCentric Therapeutics?
GeneCentric Therapeutics's investors include Alexandria Venture Investments, Hatteras Venture Partners and IAG Capital Partners.
United States · Series C startup
Who invested in GeneCentric Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $8.0MJun 2025
- Investors
- 3
The rounds
- Jun 2025Series C$8.0M
Source recordedSEC filing: $2.0M sold, first sale Jun 2025
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about GeneCentric Therapeutics
How much has GeneCentric Therapeutics raised?
GeneCentric Therapeutics has raised $8.0M across 1 round since 2025.
When did GeneCentric Therapeutics last raise?
GeneCentric Therapeutics's most recent round was a Series C of $8.0M in Jun 2025.
What was GeneCentric Therapeutics's biggest round?
Its most recent round, $8.0M in Jun 2025, is also its largest on record.
Who backed GeneCentric Therapeutics first?
GeneCentric Therapeutics's first round on record, in Jun 2025, was backed by Alexandria Venture Investments, Hatteras Venture Partners and IAG Capital Partners.
What stage is GeneCentric Therapeutics at?
GeneCentric Therapeutics's latest named round is a Series C, in Jun 2025.
Where is GeneCentric Therapeutics based?
GeneCentric Therapeutics is based in the United States.
Companies like GeneCentric Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.